Search Count: 29
 |
Organism: Severe acute respiratory syndrome coronavirus
Method: X-RAY DIFFRACTION Resolution:2.19 Å Release Date: 2025-01-29 Classification: ANTIVIRAL PROTEIN Ligands: A1H9E |
 |
Organism: Severe acute respiratory syndrome coronavirus 2
Method: X-RAY DIFFRACTION Resolution:1.90 Å Release Date: 2025-01-29 Classification: ANTIVIRAL PROTEIN Ligands: A1H9D |
 |
Organism: Severe acute respiratory syndrome coronavirus 2
Method: X-RAY DIFFRACTION Resolution:2.45 Å Release Date: 2025-01-29 Classification: ANTIVIRAL PROTEIN Ligands: A1H9Y |
 |
Organism: Severe acute respiratory syndrome coronavirus 2
Method: X-RAY DIFFRACTION Resolution:2.15 Å Release Date: 2025-01-29 Classification: ANTIVIRAL PROTEIN Ligands: A1H9Z |
 |
Organism: Severe acute respiratory syndrome coronavirus 2
Method: X-RAY DIFFRACTION Resolution:1.70 Å Release Date: 2025-01-29 Classification: ANTIVIRAL PROTEIN Ligands: A1ICP |
 |
Crystal Structure Of The Mpro Of Sars Cov-2 In Complex With The Mg-87 Inhibitor
Organism: Severe acute respiratory syndrome coronavirus 2
Method: X-RAY DIFFRACTION Resolution:2.19 Å Release Date: 2025-01-29 Classification: ANTIVIRAL PROTEIN Ligands: MXU, CL |
 |
Organism: Severe acute respiratory syndrome coronavirus 2
Method: X-RAY DIFFRACTION Resolution:1.70 Å Release Date: 2024-11-13 Classification: VIRAL PROTEIN Ligands: O6K |
 |
Organism: Severe acute respiratory syndrome coronavirus 2
Method: X-RAY DIFFRACTION Resolution:1.80 Å Release Date: 2024-11-13 Classification: VIRAL PROTEIN |
 |
Sars-Cov-2 Mpro (Omicron,P132H) In Complex With Alpha-Ketoamide 13B-K At Ph 8.5
Organism: Severe acute respiratory syndrome coronavirus 2
Method: X-RAY DIFFRACTION Resolution:2.30 Å Release Date: 2024-11-13 Classification: VIRAL PROTEIN Ligands: O6K, CL |
 |
Organism: Severe acute respiratory syndrome coronavirus 2
Method: X-RAY DIFFRACTION Resolution:2.60 Å Release Date: 2024-09-11 Classification: VIRAL PROTEIN Ligands: A1IMU |
 |
Organism: Severe acute respiratory syndrome coronavirus 2
Method: X-RAY DIFFRACTION Resolution:2.00 Å Release Date: 2024-08-07 Classification: ANTIVIRAL PROTEIN |
 |
Organism: Severe acute respiratory syndrome coronavirus 2
Method: X-RAY DIFFRACTION Resolution:1.86 Å Release Date: 2024-08-07 Classification: ANTIVIRAL PROTEIN Ligands: O6K |
 |
Organism: Severe acute respiratory syndrome coronavirus 2
Method: X-RAY DIFFRACTION Resolution:1.75 Å Release Date: 2024-08-07 Classification: ANTIVIRAL PROTEIN Ligands: 4WI |
 |
Organism: Severe acute respiratory syndrome coronavirus 2
Method: X-RAY DIFFRACTION Resolution:1.92 Å Release Date: 2024-08-07 Classification: ANTIVIRAL PROTEIN |
 |
Organism: Severe acute respiratory syndrome coronavirus 2
Method: X-RAY DIFFRACTION Resolution:2.00 Å Release Date: 2024-08-07 Classification: ANTIVIRAL PROTEIN Ligands: CL |
 |
Organism: Severe acute respiratory syndrome coronavirus 2
Method: X-RAY DIFFRACTION Resolution:2.13 Å Release Date: 2024-08-07 Classification: ANTIVIRAL PROTEIN Ligands: O6K, CL |
 |
Organism: Severe acute respiratory syndrome coronavirus 2
Method: X-RAY DIFFRACTION Resolution:2.20 Å Release Date: 2024-08-07 Classification: ANTIVIRAL PROTEIN Ligands: UAX |
 |
Organism: Severe acute respiratory syndrome coronavirus 2
Method: X-RAY DIFFRACTION Resolution:1.70 Å Release Date: 2024-02-07 Classification: ANTIVIRAL PROTEIN |
 |
Organism: Severe acute respiratory syndrome coronavirus 2
Method: X-RAY DIFFRACTION Resolution:1.69 Å Release Date: 2024-02-07 Classification: ANTIVIRAL PROTEIN Ligands: O6K |
 |
Sars-Cov-2 Mpro (Omicron, P132H) In Complex With Alpha-Ketoamide 13B-K At Ph 6.5
Organism: Severe acute respiratory syndrome coronavirus 2
Method: X-RAY DIFFRACTION Resolution:2.48 Å Release Date: 2023-11-29 Classification: VIRAL PROTEIN Ligands: O6K |